Trial No.: Medivation 3800-01
A Phase 1 Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) in Patients with Advanced Solid Tumors and Normal or Varying degrees of Renal impairment.
*Only open to Group D Severe Renal Impairment
Trial No.: BMS CA209-627 “Basket”
An Open-label Phase 2 Multi-Cohort Trial of Nivolumab in Advanced or Metastatic Malignancies.
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.